glp 1 patents Medicines Patent Pool Executive Director Charles Gore tells Devex that one of his priorities in his last year on the job is to get a license for GLP-1 therapies. But he admits The Lancet argued that 2026
Description
This condition had not been a primary focus in earlier lawsuits but is now raising significant concerns
Insurance Coverage Gaps Many insurance plans refuse to cover GLP-1 medications unless the patient also has type 2 diabetes

Because these medications slow gastric emptying, waiting three to four hours after a meal before exercising often feels better than the standard two-hour recommendation
These cells are present all the way from the duodenum to the recturm
